The devastating double-whammy of Medicare Part B payment cuts and COVID-19 has again highlighted the 340B program’s significance to hospital finance. Once relegated to the hospital’s basement pharmacy, the 340B program is increasingly a topic of boardroom and C-suite discussions.
It’s becoming increasingly difficult for Covered Entities (CEs) to effectively manage their 340B pharmacy programs. Often times understaffed relative to the task of handling the myriad of challenges that come with managing a 340B program, they face a seemingly constant barrage of maneuvering and attacks aimed at reducing their 340B benefit. In response, many Covered Entities are evaluating new strategies to strengthen or reinvigorate their program.
Join us for an educational webinar for 340B covered entities. Our webinar will provide an update on 340B legislative and legal developments. It will also provide strategies that covered entities and pharmacies are employing to protect patient access to medications and services. Speakers include Lorrie Carr, CEO of Avita and Peggy Tighe, Principal at Powers Law. Click below to register.
We are excited to announce that Assent Consulting and Washington D.C. based-Powers Law, the leading 340B law firm, have partnered together to develop a groundbreaking compliance offering – Summitt. This program is being extended to community health centers and clinics across the nation, delivering compliance confidence.
Please join our panel of four exceptional leaders, at the forefront of 340B, as they discuss the impact of women in 340B.
Referral prescriptions can be an important additional source of 340B funding for covered entities (CEs). However, it wasn’t until recently that referral prescriptions moved out of the “grey area” of 340B and into the mainstream. Just three years ago, most CEs avoided this area due to operational and compliance concerns. Today, many CEs have already added referral prescription capture to their 340B programs or are actively evaluating solutions.
Acentrus Specialty hosted its first Acentrus Specialty Conference on January 12-13, 2021, which brought together pharmacists, manufacturers, and suppliers to examine the challenges, opportunities, and best practices in advancing health system specialty pharmacy practice. A pharmacy paradigm shift is under way, as Integrated Delivery Networks (IDNs) are partnering to grow their specialty pharmacy operations.